Differentiation-dependent secretion of proangiogenic factors by mesenchymal stem cells

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Hoch, Allison I ^a   Binder, Bernard Y ^a   Genetos, Damian C ^b   Leach, J Kent ^a  

^a University of California   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; NEUTRALIZING ANTIBODY; VASCULOTROPIN; VASCULOTROPIN ANTIBODY; ALKALINE PHOSPHATASE; BONE SIALOPROTEIN; COLLAGEN TYPE 1; COLLAGEN TYPE I, ALPHA 1 CHAIN; CYTOKINE; DIFFERENTIATION ANTIGEN; FIBROBLAST GROWTH FACTOR 2; IBSP PROTEIN, HUMAN; SP7 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ARTICLE; BONE DEVELOPMENT; CELL CYCLE ARREST; CELL DIFFERENTIATION; CELL LINEAGE; CELL MIGRATION; CELL PROLIFERATION; CELL SECRETION; CHEMOTAXIS; COCULTURE; COLONY FORMING CELL; CONTROLLED STUDY; CULTURE MEDIUM; CULTURE TECHNIQUE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; PROTEIN SECRETION; ANGIOGENESIS; CELL CULTURE; CELL MOTION; CHEMISTRY; ENDOTHELIUM CELL; ENZYMOLOGY; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; PHYSIOLOGY; SECRETION;

ALKALINE PHOSPHATASE; ANTIGENS, DIFFERENTIATION; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; COLLAGEN TYPE I; CULTURE MEDIA, CONDITIONED; CYTOKINES; ENDOTHELIAL CELLS; FIBROBLAST GROWTH FACTOR 2; HUMANS; INTEGRIN-BINDING SIALOPROTEIN; MESENCHYMAL STEM CELLS; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEOGENESIS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA1; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84860008632     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0035579     Document Type: Article

References (45)

1. Schmid J, Wallkamm B, Hammerle CH, Gogolewski S, Lang NP, (1997) The significance of angiogenesis in guided bone regeneration. A case report of a rabbit experiment. Clin Oral Implants Res 8: 244-248.
2. Elbjeirami WM, West JL, (2006) Angiogenesis-like activity of endothelial cells co-cultured with VEGF-producing smooth muscle cells. Tissue Eng 12: 381-390.
3. Buschmann J, Welti M, Hemmi S, Neuenschwander P, Baltes C, et al. (2011) Three-dimensional co-cultures of osteoblasts and endothelial cells in DegraPol foam: histological and high-field magnetic resonance imaging analyses of pre-engineered capillary networks in bone grafts. Tissue Eng Part A 17: 291-299.
4. Chen L, Tredget EE, Wu PY, Wu Y, (2008) Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS One 3: e1886.
5. Huang YC, Kaigler D, Rice KG, Krebsbach PH, Mooney DJ, (2005) Combined angiogenic and osteogenic factor delivery enhances bone marrow stromal cell-driven bone regeneration. J Bone Miner Res 20: 848-857.
6. Gerber HP, Vu TH, Ryan AM, Kowalski J, Werb Z, et al. (1999) VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 5: 623-628.
7. Kanczler JM, Oreffo RO, (2008) Osteogenesis and angiogenesis: the potential for engineering bone. Eur Cell Mater 15: 100-114.
8. Haynesworth SE, Goshima J, Goldberg VM, Caplan AI, (1992) Characterization of cells with osteogenic potential from human marrow. Bone 13: 81-88.
9. Hocking AM, Gibran NS, (2010) Mesenchymal stem cells: paracrine signaling and differentiation during cutaneous wound repair. Exp Cell Res 316: 2213-2219.
10. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, et al. (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147.
11. Vater C, Kasten P, Stiehler M, (2011) Culture media for the differentiation of mesenchymal stromal cells. Acta Biomater 7: 463-477.
12. He J, Genetos DC, Leach JK, (2010) Osteogenesis and trophic factor secretion are influenced by the composition of hydroxyapatite/poly(lactide-co-glycolide) composite scaffolds. Tissue Eng Part A 16: 127-137.
13. Le Blanc K, Rasmusson I, Sundberg B, Gotherstrom C, Hassan M, et al. (2004) Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363: 1439-1441.
14. Hung SC, Pochampally RR, Chen SC, Hsu SC, Prockop DJ, (2007) Angiogenic effects of human multipotent stromal cell conditioned medium activate the PI3K-Akt pathway in hypoxic endothelial cells to inhibit apoptosis, increase survival, and stimulate angiogenesis. Stem Cells 25: 2363-2370.
15. Fierro FA, Kalomoiris S, Sondergaard CS, Nolta JA, (2011) Effects on Proliferation and Differentiation of Multipotent Bone Marrow Stromal Cells Engineered to Express Growth Factors for Combined Cell and Gene Therapy. Stem Cells.
16. Caplan AI, Dennis JE, (2006) Mesenchymal stem cells as trophic mediators. J Cell Biochem 98: 1076-1084.
17. Haynesworth SE, Baber MA, Caplan AI, (1996) Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: effects of dexamethasone and IL-1 alpha. J Cell Physiol 166: 585-592.
18. Majumdar MK, Thiede MA, Haynesworth SE, Bruder SP, Gerson SL, (2000) Human marrow-derived mesenchymal stem cells (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when differentiated toward stromal and osteogenic lineages. J Hematother Stem Cell Res 9: 841-848.
19. Coelho MJ, Fernandes MH, (2000) Human bone cell cultures in biocompatibility testing. Part II: effect of ascorbic acid, beta-glycerophosphate and dexamethasone on osteoblastic differentiation. Biomaterials 21: 1095-1102.
20. Beresford JN, Bennett JH, Devlin C, Leboy PS, Owen ME, (1992) Evidence for an Inverse Relationship between the Differentiation of Adipocytic and Osteogenic Cells in Rat Marrow Stromal Cell-Cultures. J Cell Sci 102: 341-351.
21. Cheng SL, Yang JW, Rifas L, Zhang SF, Avioli LV, (1994) Differentiation of human bone marrow osteogenic stromal cells in vitro: induction of the osteoblast phenotype by dexamethasone. Endocrinology 134: 277-286.
22. Dragoo JL, Samimi B, Zhu M, Hame SL, Thomas BJ, et al. (2003) Tissue-engineered cartilage and bone using stem cells from human infrapatellar fat pads. J Bone Joint Surg Br 85: 740-747.
23. Grunert M, Dombrowski C, Sadasivam M, Manton K, Cool SM, et al. (2007) Isolation of a native osteoblast matrix with a specific affinity for BMP2. J Mol Histol 38: 393-404.
24. Delany AM, Dong Y, Canalis E, (1994) Mechanisms of glucocorticoid action in bone cells. J Cell Biochem 56: 295-302.
25. Risau W, (1997) Mechanisms of angiogenesis. Nature 386: 671-674.
26. Staton C, Lewis C, Bicknell R, (2006) Angiogenesis Assays: A Critical Appraisal of Current Techniques London John Wiley & Sons, Ltd.
27. Saadeh PB, Mehrara BJ, Steinbrech DS, Spector JA, Greenwald JA, et al. (2000) Mechanisms of fibroblast growth factor-2 modulation of vascular endothelial growth factor expression by osteoblastic cells. Endocrinology 141: 2075-2083.
28. Mayer H, Bertram H, Lindenmaier W, Korff T, Weber H, et al. (2005) Vascular endothelial growth factor (VEGF-A) expression in human mesenchymal stem cells: autocrine and paracrine role on osteoblastic and endothelial differentiation. J Cell Biochem 95: 827-839.
29. Deckers MM, Karperien M, van der Bent C, Yamashita T, Papapoulos SE, et al. (2000) Expression of vascular endothelial growth factors and their receptors during osteoblast differentiation. Endocrinology 141: 1667-1674.
30. Furumatsu T, Shen ZN, Kawai A, Nishida K, Manabe H, et al. (2003) Vascular endothelial growth factor principally acts as the main angiogenic factor in the early stage of human osteoblastogenesis. J Biochem 133: 633-639.
31. Gruber R, Kandler B, Holzmann P, Vogele-Kadletz M, Losert U, et al. (2005) Bone marrow stromal cells can provide a local environment that favors migration and formation of tubular structures of endothelial cells. Tissue Eng 11: 896-903.
32. Leach JK, Kaigler D, Wang Z, Krebsbach PH, Mooney DJ, (2006) Coating of VEGF-releasing scaffolds with bioactive glass for angiogenesis and bone regeneration. Biomaterials 27: 3249-3255.
33. Patel ZS, Young S, Tabata Y, Jansen JA, Wong ME, et al. (2008) Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model. Bone 43: 931-940.
34. Hariawala MD, Horowitz JR, Esakof D, Sheriff DD, Walter DH, et al. (1996) VEGF improves myocardial blood flow but produces EDRF-mediated hypotension in porcine hearts. J Surg Res 63: 77-82.
35. Bischoff DS, Zhu JH, Makhijani NS, Kumar A, Yamaguchi DT, (2008) Angiogenic CXC chemokine expression during differentiation of human mesenchymal stem cells towards the osteoblastic lineage. J Cell Biochem 103: 812-824.
36. Schubert T, Xhema D, Veriter S, Schubert M, Behets C, et al. (2011) The enhanced performance of bone allografts using osteogenic-differentiated adipose-derived mesenchymal stem cells. Biomaterials 32: 8880-8891.
37. Aguirre A, Planell JA, Engel E, (2010) Dynamics of bone marrow-derived endothelial progenitor cell/mesenchymal stem cell interaction in co-culture and its implications in angiogenesis. Biochem Biophys Res Commun 400: 284-291.
38. Grellier M, Ferreira-Tojais N, Bourget C, Bareille R, Guillemot F, et al. (2009) Role of vascular endothelial growth factor in the communication between human osteoprogenitors and endothelial cells. J Cell Biochem 106: 390-398.
39. Jaiswal N, Haynesworth SE, Caplan AI, Bruder SP, (1997) Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem 64: 295-312.
40. Yoder MC, Mead LE, Prater D, Krier TR, Mroueh KN, et al. (2007) Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 109: 1801-1809.
41. He J, Genetos DC, Yellowley CE, Leach JK, (2010) Oxygen tension differentially influences osteogenic differentiation of human adipose stem cells in 2D and 3D cultures. J Cell Biochem 110: 87-96.
42. Decaris ML, Lee CI, Yoder MC, Tarantal AF, Leach JK, (2009) Influence of the oxygen microenvironment on the proangiogenic potential of human endothelial colony forming cells. Angiogenesis 12: 303-311.
43. Aozuka Y, Koizumi K, Saitoh Y, Ueda Y, Sakurai H, et al. (2004) Anti-tumor angiogenesis effect of aminopeptidase inhibitor bestatin against B16-BL6 melanoma cells orthotopically implanted into syngeneic mice. Cancer Lett 216: 35-42.
44. Nakatsu MN, Davis J, Hughes CC, (2007) Optimized fibrin gel bead assay for the study of angiogenesis. J Vis Exp pp. 186.
45. Ghajar CM, Chen X, Harris JW, Suresh V, Hughes CC, et al. (2008) The effect of matrix density on the regulation of 3-D capillary morphogenesis. Biophys J 94: 1930-1941.